What is the ticker symbol for GeoVax Labs?

GeoVax Labs trades under the ticker GOVX on NASDAQ.

What sector does GeoVax Labs operate in?

GeoVax Labs is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GOVX in a portfolio?

PortView shows GOVX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

GeoVax Labs (GOVX) Stock Analysis

NASDAQHealthcareBiotechnology

$0.59-1.85%

1-year price historyRange $0.59 – $18.67

52-week range$0.59

$0.59$19.20

What GeoVax Labs does

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.

Key metrics

Market cap

$4.38M

P/E (TTM)

-0.05

EPS (TTM)

$-13.01

Beta

3.66

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.89

200-day avg

$2.75

52-week high

$19.20

52-week low

$0.59

CEO

David Alan Dodd

ETFs linked to GOVX

Broad-market and Healthcare sector ETFs an investor holding GeoVax Labs is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GOVX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GOVX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for GeoVax Labs?: GeoVax Labs trades under the ticker GOVX on NASDAQ.
Which exchange is GOVX listed on?: GOVX is listed on NASDAQ.
What sector does GeoVax Labs operate in?: GeoVax Labs is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GOVX in a portfolio?: PortView shows GOVX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.